Abstract
Platelet-rich plasma (PRP) is currently used in regenerative medicine and has opened up an exciting field of study. In this chapter, we present the main challenges limiting the study and standardization of PRP, based on variables and interactions involved in its preparation. Furthermore, we present and discuss some approaches to basic science studies of PRP from the simplest case to the most complex or real scenario. A feasible strategy for studying P-PRP (Pure-PRP) preparation in a real situation is also illustrated. The key point of the strategy is the predictive description of the main steps of PRP preparation, based on the physicochemical events. Within the expected variability for an autologous product, the quality of PRP can be modulated by preparation conditions and also tailored for evaluation of biological responses. The interconnected characterization and standardization of the quality and biological properties of PRP are the basis for further clinical studies
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Anitua E, Aguirre JJ, Algorta J, Ayerdi E, Cabezas AI, Orive G, Andia I (2008) Effectiveness of autologous preparation rich in growth factors for the treatment of chronic cutaneous ulcers. J Biomed Mater Res B Appl Biomater 84(2):415–421
Anitua E, Alkhraisat MH, Orive G (2012) Perspectives and challenges in regenerative medicine using plasma rich in growth factors. J Controlled Release 157(1):29–38
Anitua E, Sanchez M, Nurden AT, Zalduendo MM, de la Fuente M, Azofra J, Andia I (2007) Platelet-released growth factors enhance the secretion of hyaluronic acid and induce hepatocyte growth factor production by synovial fibroblasts from arthritic patients. Rheumatology (Oxford) 46(12):1769–1772
Araki J, Jona M, Eto H, Aoi N, Kato H, Suga H, Doi K, Yatomi Y, Yoshimura K (2012) Optimized preparation method of platelet-concentrated plasma and noncoagulating platelet-derived factor concentrates: maximization of platelet concentration and removal of fibrinogen. Tissue Eng Part C Methods 18(3):176–185
Sa Arnoczky, Caballero O (2010) Platelet-rich plasma to augment connective tissue healing: making sense of it all. J Am Acad Orthop Surg 18:2
Arnoczky SD, Rodeo SA D (2011) What is platelet-rich plasma? Oper Tech Sports Med 19:142–148
Bailey JE, Ollis DF (1986) Biochemical engineering fundamentals, 2nd edn. McGraw-Hill, Inc, New York
Bäumler H, Neu B, Donath E, Kiesewetter H (1999) Basic phenomena of red blood cell rouleaux formation. Biorheology 36(5):439–442
Bausset O, Giraudo L, Veran J, Magalon J, Coudreuse J-M, Magalon G, Dubois C, Serratrice N, Dignat-George F, Sabatier F (2012) Formulation and storage of platelet-rich plasma homemade product
Bird RB, Stewart WE, Lightfoot EN (2007) Transport phenomena, 2nd edn.John Wiley & Sons. ISBN:978-0-470-11539-8
Carr ME (1990). Patent US5118182—Method for determining fibrin fiber size from a single gel optical density measurement
Carr ME, Gabriel DA (1980) Dextran-induced changes in fibrin fiber size and density based on wavelength dependence of gel turbidity
Carr ME Jr, Gabriel DA, McDonagh J (1986) Influence of Ca2 + on the structure of reptilase-derived and thrombin-derived fibrin gels. Biochem J 239(3):513–516
Dohan Ehrenfest DM, Bielecki T, Jimbo R, Barbe G, Del Corso M, Inchingolo F, Sammartino G (2012) Do the fibrin architecture and leukocyte content influence the growth factor release of platelet concentrates? An evidence-based answer comparing a pure platelet-rich plasma (P-PRP) gel and a leukocyte- and platelet-rich fibrin (L-PRF). Curr Pharm Biotechnol 13(7):1145–1152
Dohan Ehrenfest DM, Rasmusson L, Albrektsson T (2009) Classification of platelet concentrates: from pure platelet-rich plasma (P-PRP) to leucocyte- and platelet-rich fibrin (L-PRF). Trends Biotechnol 27(3):158–167
El-Sharkawy H, Kantarci A, Deady J, Hasturk H, Liu H, Alshahat M, Van Dyke TE (2007) Platelet-rich plasma: growth factors and pro- and anti-inflammatory properties. J Periodontol 78(4):661–669
Engebretsen L, Steffen K, Alsousou J, Anitua E, Bachl N, Devilee R, Everts P, Hamilton B, Huard J, Jenoure P (2010) IOC consensus paper on the use of platelet-rich plasma in sports medicine. Br J Sports Med 44(15):1072–1081
Everts PA, Overdevest EP, Jakimowicz JJ, Oosterbos CJ, Schonberger JP, Knape JT, van Zundert A (2007) The use of autologous platelet-leukocyte gels to enhance the healing process in surgery, a review. Surg Endosc 21(11):2063–2068
Foster TE, Puskas BL, Mandelbaum BR, Gerhardt MB, Rodeo SA (2009) Platelet-rich plasma from basic science to clinical applications. Am J Sports Med 37(11):2259–2272
Franco D, Franco T, Schettino AM, Tavares Filho JM, Vendramin FS (2012) Protocol for obtaining platelet-rich plasma (PRP), platelet-poor plasma (PPP), and thrombin for autologous use. Aesthetic Plast Surg 36(5):1254–1259
Hom DB, Linzie BM, Huang TC (2007) The healing effects of autologous platelet gel on acute human skin wounds. Arch Facial Plast Surg 9(3):174–183
Hunter RJ (2001) Foundations of colloid science, 2nd edn. Oxford University Press, USA
Kersaudy-Kerhoas M, Dhariwal R, Desmulliez MY, Jouvet L (2010) Hydrodynamic blood plasma separation in microfluidic channels. Microfluid Nanofluid 8(1):105–114
Lacoste E, Martineau I, Gagnon G (2003) Platelet concentrates: effects of calcium and thrombin on endothelial cell proliferation and growth factor release. J Periodontol 74(10):1498–1507
Landesberg R, Roy M, Glickman RS (2000) Quantification of growth factor levels using a simplified method of platelet-rich plasma gel preparation. J Oral Maxillofac Surg 58(3):297–300
Lei H, Gui L, Xiao R (2009) The effect of anticoagulants on the quality and biological efficacy of platelet-rich plasma. Clin Biochem 42(13):1452–1460
Martineau I, Lacoste E, Gagnon G (2004) Effects of calcium and thrombin on growth factor release from platelet concentrates: kinetics and regulation of endothelial cell proliferation. Biomaterials 25(18):4489–4502
Marx RE (2001) Platelet-rich plasma (PRP): what is PRP and what is not PRP? Implant dent 10(4):225–228
Mazzocca AD, McCarthy MBR, Chowaniec DM, Cote MP, Romeo AA, Bradley JP, Arciero RA, Beitzel K (2012) Platelet-rich plasma differs according to preparation method and human variability. J Bone Joint Surg 94(4):308–316
McCarrel T, Fortier L (2009) Temporal growth factor release from platelet-rich plasma, trehalose lyophilized platelets, and bone marrow aspirate and their effect on tendon and ligament gene expression. J Orthop Res 27(8):1033–1042
Mei-Dan O, Carmont M, Kots E, Barchilon V, Nyska M, Mann G (2010) Early return to play following complete rupture of the medial collateral ligament of the elbow using preparation rich in growth factors: a case report. J Shoulder Elbow Surg 19(5):e1–e5
Mosesson MW, Siebenlist KR, Meh DA (2001) The structure and biological features of fibrinogen and fibrin. Ann N Y Acad Sci 936(1):11–30
Neto BdB, Scarminio IS, Bruns RE (2001) Planejamento e otimização de experimentos, 2nd ed Campinas,SP, Brazil, Editora Unicamp
Perez AGM, Lichy R, Lana JF, Rodriguez AA, Luzo ACM, Belangero WD, Santana MHA Prediction and modulation of platelet recovery by discontinuous centrifugation of whole blood for preparation of pure platelet-rich plasma. BioResearch Open Acces. ISSN: 2164–7860. doi:10.1089/biores.2013.0015 [InPress]
Press R. (2012) Platelet-rich plasma: For now, more questions than answers. Orthopedics today. http://www.healio.com/orthopedics/biologics/news/print/orthopedics-today/%7B5F7A0187-359E−4F2A-BFC8-2425AA213BC1%7D/Platelet-rich-plasma-For-now-more-questions-than-answers
Riha P, Liao F, Stoltz J-F (1997) The effect of rouleaux formation on blood coagulation. Manuscript presented at the symposium on cellular aggregation and adhesion held at the 21st French congress on biomechanics and the 9th French congress on biorheology, Sept 1996. Clin Hemorheol Microcirc 17(4): 341–346
Sundman EA, Cole BJ, Fortier LA (2011) Growth factor and catabolic cytokine concentrations are influenced by the cellular composition of platelet-rich plasma. Am J Sports Med 39:2135–2140
van den Dolder J, Mooren R, Vloon AP, Stoelinga PJ, Jansen JA (2006) Platelet-rich plasma: quantification of growth factor levels and the effect on growth and differentiation of rat bone marrow cells. Tissue Eng 12(11):3067–3073
Wasterlain AS, Braun HJ, Dragoo JL (2012) Contents and formulations of platelet-rich plasma. Operative Tech Orthop 22(1):33–42
Weisel JW, Nagaswami C (1993) Computer modeling of fibrin polymerization kinetics correlated with electron microscope and turbidity observations: clot structure and assembly are kinetically controlled
Werynski A, Malchesky PS, Sueoka A, Asanuma Y, Smith JW, Kayashima K, Herpy E, Sato H, Nosé Y (1981) Membrane plasma separation: toward improved clinical operation. ASAIO J 27:539–543
Wojtys EM (2012) The PRP question. Sports Health: Multi Approach 4(2):99–100
Wolberg AS (2007) Thrombin generation and fibrin clot structure. Blood Rev 21(3):131–142
Yeromonahos C, Polack B, Caton F (2007) Nanostructure of the FibrinClot. Biophys J 99(7):2018–2027
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Perez, A.G.M., Lana, J.F., Rodrigues, A.A., Luzo, A.C.M., Belangero, W.D., Santana, M.H.A. (2014). Challenges and a Feasible Strategy for Studies and Standardization of Platelet-Rich Plasma. In: Lana, J., Andrade Santana, M., Dias Belangero, W., Malheiros Luzo, A. (eds) Platelet-Rich Plasma. Lecture Notes in Bioengineering. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-40117-6_4
Download citation
DOI: https://doi.org/10.1007/978-3-642-40117-6_4
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-40116-9
Online ISBN: 978-3-642-40117-6
eBook Packages: EngineeringEngineering (R0)